Related Experiment Video
Updated: Aug 6, 2026

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
Published on: November 25, 2022
Glucocerebrosidase rescues alpha-synuclein from amyloid formation in vitro
Michael Barber1, Henrik Muller1, Robert J C Gilbert2
1Department of Chemistry, University of Oxford, Physical and Theoretical Chemistry Laboratory, Oxford OX1 3QZ, UK.
None:
Alpha-synuclein (αSyn) is a lipid-binding protein that assembles into amyloid fibrils in Parkinson's disease (PD). Lipid binding can accelerate the rate of αSyn fibril formation by stimulating primary nucleation. Recently, the lysosomal protein glucocerebrosidase (GCase) has been identified as a major risk factor in both genetic and sporadic PD. Using solution-state nuclear magnetic resonance spectroscopy, we observe that GCase binds to the C-terminal region of αSyn and attenuates the lipid-binding affinity of αSyn. Mechanistically, this interaction model involves competition between lipids and GCase for αSyn, with lipids and GCase preferentially interacting with the N- and C-terminal regions respectively, in a tug-of-war mechanism. Moreover, the addition of GCase to mature αSyn fibrils increases the NMR-visible population of flexible αSyn, indicating altered fibril-associated αSyn dynamics. Our findings provide a mechanistic explanation for the observed links between changes in GCase abundance and PD.
More Related Videos
09:16Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
Published on: June 26, 2018
11:57Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase
Published on: June 24, 2025